Hemispherx Biopharma Awarded $770,852 by Federal Judge | 7:30 AM |
[GlobeNewswire] - WILMINGTON, Del. -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that after prevailing in a federal lawsuit brought against the Company by Cato ...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.